• Research & Development

  New Clinical Trial Shows Apelin Improves Cardiac Function in PAH

  Posted by Pulmonary Hypertension News Moderator on June 25, 2018 at 8:12 am

  Apelin, a peptide naturally produced in our body, reduces resistance in blood vessels and improves cardiac function in pulmonary arterial hypertension patients with, trial results show.

  Read more about it here: Apelin Improves Pulmonary and Cardiac Functions in PAH Patients, Clinical Trial Shows

  What are your thoughts on this news?

  replied 5 years, 11 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply